Recruiting

Testing a nutritional supplement to protect the optic nerve in glaucoma

Plain-English translation of NCT07322965 on ClinicalTrials.gov ↗ · Source last updated January 2026 · Translation generated June 2026 · How we translate trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

What is this trial?

This trial is testing BRUDYGLAUCO, a nutritional supplement made from two natural compounds called DHA and citicoline, in people with glaucoma. Glaucoma damages the optic nerve and can lead to vision loss or blindness. While current eye drops help control eye pressure, researchers want to see if this medication might offer extra protection to the nerve itself.

Standard glaucoma treatments focus mainly on lowering eye pressure, but vision still continues to decline in many patients. This study exists to explore whether the treatment might protect the optic nerve from further damage and help preserve sight longer.

Do you qualify?

You likely qualify if…

you have been diagnosed with glaucoma (in at least one eye) with clear signs of nerve damage seen on eye imaging
you are between 50 and 75 years old
you have had at least 4 reliable visual field tests before enrolling
your glaucoma damage is moderate—not too early and not so advanced that treatment options are limited

You likely don't qualify if…

you are currently taking vitamin or nutritional supplements (you would need to stop them one month before joining)
you have other eye diseases or neurological conditions that could affect vision testing
you are allergic to aspirin, as there is a possible cross-reaction with one of the supplement ingredients
you have had eye surgery or laser treatment in the last 3 months or are planning any during the study
your advanced cataracts or other conditions would make it impossible to accurately measure your vision

What participation looks like

You would take two capsules at lunchtime every day for 12 months—either the actual supplement or a placebo (dummy pill), decided by random chance. You would visit the eye clinic regularly for vision tests and eye exams to measure whether your vision is changing. At 6 months, researchers will check early results, and at the end of 12 months, they will measure whether the treatment helped slow vision loss compared to the placebo group.

AI-generated summary from trial data · Jun 6, 2026 · Not medical advice

Testing a nutritional supplement to protect the optic nerve in glaucoma

What is this trial?

Do you qualify?

What participation looks like

Trial locations